# ADME Study of [14C]ICP-022 in Healthy Males

> **NCT04441450** · NA · COMPLETED · sponsor: **Beijing InnoCare Pharma Tech Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]ICP-022

## Key facts

- **NCT ID:** NCT04441450
- **Lead sponsor:** Beijing InnoCare Pharma Tech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04441450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04441450, "ADME Study of [14C]ICP-022 in Healthy Males". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04441450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*